SPOiLER: towards Safer Prescribing of Legal Opioids from the Emergency Room
剧透:在急诊室更安全地开出合法阿片类药物
基本信息
- 批准号:10364730
- 负责人:
- 金额:$ 18.47万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2018
- 资助国家:美国
- 起止时间:2018-03-01 至 2023-08-31
- 项目状态:已结题
- 来源:
- 关键词:Accident and Emergency departmentAcuteApplications GrantsAttitudeBehaviorBehavioralBeliefBenefits and RisksCharacteristicsChronicClinicalCohort AnalysisDataDatabasesDependenceDevelopmentDrug MonitoringDrug PrescriptionsEducationEmergency Department PhysicianEmergency Department patientEmergency SituationEpidemicEquilibriumEventEvidence based practiceFrequenciesFundingFutureGoalsGrantHarm ReductionHospitalsIndividualInterviewLeadershipLegalMassachusettsMentorsMethodsNational Institute of Drug AbuseNew HampshireOpioidOutpatientsOverdosePainPatient-Focused OutcomesPatientsPhysiciansPlanning TheoryPoliciesPolicy ResearchProbabilityProviderQualitative MethodsQuasi-experimentRegulationResearchResearch PersonnelResearch Project GrantsRetrospective cohortRiskRoleState GovernmentStatutes and LawsStructureSubstance Use DisorderTrainingUnited Statesaddictionadverse outcomebasebehavior changebehavioral outcomecareer developmentclinically relevantevidence baseevidence based guidelinesexperiencehealth care service utilizationimplementation trialindexingnonmedical useopioid epidemicopioid policyopioid therapyopioid useopioid use disorderpeerpillprescription opioidpreventsocial normtheories
项目摘要
PROJECT SUMMARY
The objective of this NIDA K08 career development proposal is to gain experience and training to
become an independent investigator focused on the development of evidence-based practices to prevent and
treat substance use disorders in the emergency department. Opioid use disorders, including overdose and
addiction, have become epidemic in the United States. While research has largely focused on long-term opioid
prescribing in the outpatient setting, emergency department opioid prescribing for acute painful conditions as a
portal for future adverse patient outcomes remains poorly defined.
State governments, including the Commonwealth of Massachusetts, have reacted to the opioid crisis in
part by crafting legislation to broadly limit legal opioid prescriptions. However, opioid medications remain an
important treatment option for some acute painful conditions, and evidence based guidance on appropriate
prescribing is lacking, in part because the factors that impact providers opioid prescribing behaviors and
subsequent patient associated adverse outcomes remains unknown. Understanding the underlying
factors that influence opioid prescribing behaviors and future patient outcomes, including state legislation, peer
behaviors, hospital attitudes, and local culture, is a critical step in developing integrated, evidence-based
recommendations that focus on transforming the culture surrounding safe opioid prescribing practices.
Using the theory of planned behavior as a framework, the goals of this K08 grant application are to
understand opioid prescribing behaviors and adverse patient outcomes through the following aims: First, we
will assess the influence of state legislation, specifically the 2016 Massachusetts (MA) Opioid Law, on the
formation of hospital-based regulations and providers' perceived attitudes towards opioid prescribing through
qualitative interviews with local physician leaders in MA. Second, using comprehensive claims data, we will
evaluate the impact of the 2016 MA Opioid Law on statewide opioid prescribing, using a neighboring state
without opioid legislation as a natural control. Finally, we will examine the association of an initial opioid
prescription on clinically relevant patient outcomes in order to better understand how restricting opioid
prescriptions through legislation may impact emergency department patients presenting with an acute painful
condition.
From our results, we will create evidence-based recommendations to enhance existing opioid
legislation, as well as develop and execute R01 funded comprehensive implementation trials that focus not
only on changing behaviors of individual providers, but also transforming the group culture and social norms
that influence opioid prescribing behaviors.
!
项目总结
项目成果
期刊论文数量(9)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
William Edward Soares其他文献
William Edward Soares的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('William Edward Soares', 18)}}的其他基金
SPOiLER: towards Safer Prescribing of Legal Opioids from the Emergency Room
剧透:在急诊室更安全地开出合法阿片类药物
- 批准号:
10116352 - 财政年份:2018
- 资助金额:
$ 18.47万 - 项目类别:
相似海外基金
Transcriptional assessment of haematopoietic differentiation to risk-stratify acute lymphoblastic leukaemia
造血分化的转录评估对急性淋巴细胞白血病的风险分层
- 批准号:
MR/Y009568/1 - 财政年份:2024
- 资助金额:
$ 18.47万 - 项目类别:
Fellowship
Combining two unique AI platforms for the discovery of novel genetic therapeutic targets & preclinical validation of synthetic biomolecules to treat Acute myeloid leukaemia (AML).
结合两个独特的人工智能平台来发现新的基因治疗靶点
- 批准号:
10090332 - 财政年份:2024
- 资助金额:
$ 18.47万 - 项目类别:
Collaborative R&D
Acute senescence: a novel host defence counteracting typhoidal Salmonella
急性衰老:对抗伤寒沙门氏菌的新型宿主防御
- 批准号:
MR/X02329X/1 - 财政年份:2024
- 资助金额:
$ 18.47万 - 项目类别:
Fellowship
Cellular Neuroinflammation in Acute Brain Injury
急性脑损伤中的细胞神经炎症
- 批准号:
MR/X021882/1 - 财政年份:2024
- 资助金额:
$ 18.47万 - 项目类别:
Research Grant
KAT2A PROTACs targetting the differentiation of blasts and leukemic stem cells for the treatment of Acute Myeloid Leukaemia
KAT2A PROTAC 靶向原始细胞和白血病干细胞的分化,用于治疗急性髓系白血病
- 批准号:
MR/X029557/1 - 财政年份:2024
- 资助金额:
$ 18.47万 - 项目类别:
Research Grant
Combining Mechanistic Modelling with Machine Learning for Diagnosis of Acute Respiratory Distress Syndrome
机械建模与机器学习相结合诊断急性呼吸窘迫综合征
- 批准号:
EP/Y003527/1 - 财政年份:2024
- 资助金额:
$ 18.47万 - 项目类别:
Research Grant
FITEAML: Functional Interrogation of Transposable Elements in Acute Myeloid Leukaemia
FITEAML:急性髓系白血病转座元件的功能研究
- 批准号:
EP/Y030338/1 - 财政年份:2024
- 资助金额:
$ 18.47万 - 项目类别:
Research Grant
STTR Phase I: Non-invasive focused ultrasound treatment to modulate the immune system for acute and chronic kidney rejection
STTR 第一期:非侵入性聚焦超声治疗调节免疫系统以治疗急性和慢性肾排斥
- 批准号:
2312694 - 财政年份:2024
- 资助金额:
$ 18.47万 - 项目类别:
Standard Grant
ロボット支援肝切除術は真に低侵襲なのか?acute phaseに着目して
机器人辅助肝切除术真的是微创吗?
- 批准号:
24K19395 - 财政年份:2024
- 资助金额:
$ 18.47万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Acute human gingivitis systems biology
人类急性牙龈炎系统生物学
- 批准号:
484000 - 财政年份:2023
- 资助金额:
$ 18.47万 - 项目类别:
Operating Grants














{{item.name}}会员




